Authors: SMITH AD GEISLER SC CHEN AA RESNICK DA ROY BM LEWI PJ ARNOLD E ARNOLD GF

Citation: Ad. Smith et al., HUMAN RHINOVIRUS TYPE-14 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) V3 LOOP CHIMERAS FROM A COMBINATORIAL LIBRARY INDUCE POTENT NEUTRALIZING ANTIBODY-RESPONSES AGAINST HIV-1, Journal of virology, 72(1), 1998, pp. 651-659

Authors: HOOKER DJ TACHEDJIAN G SOLOMON AE GURUSINGHE AD LAND S BIRCH C ANDERSON JL ROY BM ARNOLD E DEACON NJ

Citation: Dj. Hooker et al., AN IN-VIVO MUTATION FROM LEUCINE TO TRYPTOPHAN AT POSITION-210 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONTRIBUTES TO HIGH-LEVEL RESISTANCE TO 3'-AZIDO-3'-DEOXYTHYMIDINE, Journal of virology, 70(11), 1996, pp. 8010-8018

Authors: ARNOLD E DAS K DING JP HSIOU Y TANTILLO C ROY BM YADAV P ZHANG WY LENTZ K CLARK AD BOYER PL HUGHES SH MITSUYA H MELLORS J KLEIM JP ROSNER M MOEREELS HR KOYMANS L ANDRIES K PAUWELS R JANSSEN PAJ

Citation: E. Arnold et al., THE ROLE OF NUCLEIC-ACID IN THE RESISTANCE OF HIV-1 REVERSE-TRANSCRIPTASE TO NUCLEOSIDE AND NONNUCLEOSIDE INHIBITORS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 7-7

Authors: MELLORS JW BAZMI HZ SCHINAZI RF ROY BM HSIOU Y ARNOLD E WEIR J MAYERS DL

Citation: Jw. Mellors et al., NOVEL MUTATIONS IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REDUCE SUSCEPTIBILITY TO FOSCARNET IN LABORATORY AND CLINICAL ISOLATES, Antimicrobial agents and chemotherapy, 39(5), 1995, pp. 1087-1092

Authors: SHIRASAKA T KAVLICK MF UENO T GAO WY KOJIMA E ALCAIDE ML CHOKEKIJCHAI S ROY BM ARNOLD E YARCHOAN R MITSUYA H

Citation: T. Shirasaka et al., EMERGENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH RESISTANCE TO MULTIPLE DIDEOXYNUCLEOSIDES IN PATIENTS RECEIVING THERAPY WITHDIDEOXYNUCLEOSIDES, Proceedings of the National Academy of Sciences of the United Statesof America, 92(6), 1995, pp. 2398-2402